{
    "clinical_study": {
        "@rank": "65626", 
        "arm_group": [
            {
                "arm_group_label": "Sevoflurane", 
                "arm_group_type": "Active Comparator", 
                "description": "Sevoflurane Based Volatile Induction and Maintenance of Anaesthesia"
            }, 
            {
                "arm_group_label": "Propofol", 
                "arm_group_type": "Active Comparator", 
                "description": "Propofol Based Total Intravenous Anesthesia"
            }
        ], 
        "brief_summary": {
            "textblock": "The aim of this study is to distinguish possible differences in frequency of delirium after\n      Volatile Induction and Maintenance of Anesthesia  and Total Intravenous Anesthesia  in case\n      of undeliberate cerebral desaturation during non-cardiac surgery."
        }, 
        "brief_title": "Sevoflurane Decreases the Risk of Postoperative Delirium After Cerebral Hypoxemia During Surgery", 
        "completion_date": {
            "#text": "June 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Cerebral Hypoxia", 
            "Postoperative Delirium"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Delirium", 
                "Anoxia", 
                "Hypoxia, Brain"
            ]
        }, 
        "detailed_description": {
            "textblock": "The aim of the present study is to investigate whether in non-cardiac surgery the frequency\n      of POD after intraoperative undeliberate cerebral saturation could be modulated by the\n      choice of the anesthetic strategy (Volatile Induction and Maintenance of Anesthesia [VIMA]\n      and Total Intravenous Anesthesia [TIVA]). Based on our previous data we hypothesized that\n      incidence of POD would be lower with VIMA compared to TIVA."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  class III-IV  by physical status classification system of American Society of\n             Anesthesiologist (ASA)\n\n          -  history of arterial vascular disease (arterial hypertension, myocardial ischemia\n             and/or cerebral vascular disease)\n\n          -  undergoing elective non-cardiac surgery (hemicolectomy, hernioplasty, laparoscopic\n             cholecystectomy and laparoscopic hysterectomy)\n\n        Exclusion Criteria:\n\n          -  dementia\n\n          -  stroke or myocardial infarction \u2264 6 months before surgery\n\n          -  oncological disease of T2-4N3M1 stage"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "65 Years"
        }, 
        "enrollment": {
            "#text": "130", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 6, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02133638", 
            "org_study_id": "Sev003", 
            "secondary_id": "s100b"
        }, 
        "intervention": [
            {
                "arm_group_label": "Sevoflurane", 
                "description": "Induction of anesthesia: fentanyl 2 \u00b5g kg-1 and a bolus inhalation of 8% sevoflurane in an 8 L.min-1 fresh gas flow. Anesthesia maintenance: 1 minimal alveolar concentration (MAC) sevoflurane at a low fresh gas flow of 0.6-0.8 L min-1 in a 60% air-oxygen mixture supplemented with boluses of fentanyl.", 
                "intervention_name": "Sevoflurane", 
                "intervention_type": "Drug", 
                "other_name": [
                    "Sevorane", 
                    "Ultane", 
                    "Fluoromethyl hexafluoroisopropyl ether"
                ]
            }, 
            {
                "arm_group_label": "Propofol", 
                "description": "Induction of anesthesia: propofol 2 mg kg-1 and fentanyl 4 \u00b5g kg-1. Maintenance of anesthesia: infusion of propofol 8 mg kg-1 h-1 and boluses of fentanyl 3 \u00b5g kg-1.", 
                "intervention_name": "Propofol", 
                "intervention_type": "Drug", 
                "other_name": [
                    "Diprivan", 
                    "Lipuro", 
                    "Propolipid", 
                    "Propoven", 
                    "Recofol", 
                    "Unifol"
                ]
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Anesthetics", 
                "Propofol", 
                "Sevoflurane"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Delirium", 
            "Hypoxic Brain Damage", 
            "Propofol", 
            "S100b protein", 
            "Sevoflurane"
        ], 
        "lastchanged_date": "May 6, 2014", 
        "location": {
            "contact": {
                "email": "skripkin62@gmail.com", 
                "last_name": "Yuri V. Skripkin"
            }, 
            "facility": {
                "address": {
                    "city": "Moscow", 
                    "country": "Russian Federation"
                }, 
                "name": "Medical center of the Main Administration for Service to the Diplomatic Corps"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Russian Federation"
        }, 
        "number_of_arms": "2", 
        "official_title": "Sevoflurane-based Volatile Induction and Maintenance of Anaesthesia (VIMA) Strategy Decreases the Risk of Postoperative Delirium in Elderly Patients With Registered Cerebral Hypoxemia Episodes During General Surgery", 
        "overall_contact": {
            "email": "lik0704@gmail.com", 
            "last_name": "Valery V. Likhvantsev, MD, Prof."
        }, 
        "overall_official": [
            {
                "affiliation": "Negovsky Reanimatology Research Institute, Moscow, Russia", 
                "last_name": "Valery V. Likhvantsev, MD, Prof.", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "Negovsky Reanimatology Research Institute, Moscow, Russia", 
                "last_name": "Oleg A. Grebenchikov, MD, PhD", 
                "role": "Study Director"
            }, 
            {
                "affiliation": "Negovsky Reanimatology Research Institute, Moscow, Russia", 
                "last_name": "Yuri V. Iljin", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Negovsky Reanimatology Research Institute, Moscow, Russia", 
                "last_name": "Alexander V. Mironenko, MD, PhD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Negovsky Reanimatology Research Institute, Moscow, Russia", 
                "last_name": "Yuri V. Skripkin", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Hospital Maria Vittoria, Turin, Italy", 
                "last_name": "Dmitriy B. Selivanov, MD, PhD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Russia: Ministry of Health of the Russian Federation", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "May 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "Regional Cerebral Oxygenation  (rSO2)", 
                "safety_issue": "Yes", 
                "time_frame": "Continued the entire surgery"
            }, 
            {
                "measure": "Peripheral tissue oxygen saturation (SpO2)", 
                "safety_issue": "Yes", 
                "time_frame": "Continued the entire surgery"
            }, 
            {
                "measure": "Non-invasive blood pressure (NIBP)", 
                "safety_issue": "Yes", 
                "time_frame": "Continued the entire surgery"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02133638"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Applying the Confusion Assessment Method for the ICU (CAM-ICU)", 
                "measure": "Number of Incidences of postoperative delirium (POD)", 
                "safety_issue": "Yes", 
                "time_frame": "Baseline, 24h and 48h after surgery"
            }, 
            {
                "description": "S100b protein is the neuronal injury marker", 
                "measure": "Plasma concentration of S100b protein", 
                "safety_issue": "Yes", 
                "time_frame": "Baseline, 24h and 48h after surgery"
            }
        ], 
        "source": "Negovsky Reanimatology Research Institute", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Negovsky Reanimatology Research Institute", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Pharmacodynamics Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}